Literature DB >> 24597601

Sphingosine-1-phosphate receptor 1 signalling in T cells: trafficking and beyond.

Christopher S Garris1, Victoria A Blaho, Timothy Hla, May H Han.   

Abstract

Sphingosine-1-phosphate (S1P) is a lipid second messenger that signals via five G protein-coupled receptors (S1P1-5 ). S1P receptor (S1PR) signalling is associated with a wide variety of physiological processes including lymphocyte biology, their recirculation and determination of T-cell phenotypes. The effect of FTY720 (Fingolimod, Gilenya™) to regulate lymphocyte egress and to ameliorate paralysis in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis led to the use of FTY720 as a first-line oral agent for treatment of relapsing-remitting multiple sclerosis. However, a significant body of research suggests that S1P signalling may participate in diverse immune regulatory functions other than lymphocyte trafficking. This review article discusses the current knowledge of S1P signalling in the fate and function of T regulatory, T helper type 17 and memory T cells in health and disease.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  T cells; immune cells; sphingosine 1-phosphate

Mesh:

Substances:

Year:  2014        PMID: 24597601      PMCID: PMC4080950          DOI: 10.1111/imm.12272

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  67 in total

1.  Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients.

Authors:  Susan R Schwab; João P Pereira; Mehrdad Matloubian; Ying Xu; Yong Huang; Jason G Cyster
Journal:  Science       Date:  2005-09-09       Impact factor: 47.728

2.  Synthesis and biological evaluation of 2,2-disubstituted 2-aminoethanols: analogues of FTY720.

Authors:  M Kiuchi; K Adachi; T Kohara; K Teshima; Y Masubuchi; T Mishina; T Fujita
Journal:  Bioorg Med Chem Lett       Date:  1998-01-06       Impact factor: 2.823

Review 3.  Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network.

Authors:  Hugh Rosen; Edward J Goetzl
Journal:  Nat Rev Immunol       Date:  2005-07       Impact factor: 53.106

4.  FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing.

Authors:  K Chiba; Y Yanagawa; Y Masubuchi; H Kataoka; T Kawaguchi; M Ohtsuki; Y Hoshino
Journal:  J Immunol       Date:  1998-05-15       Impact factor: 5.422

5.  Immunological effects of transgenic constitutive expression of the type 1 sphingosine 1-phosphate receptor by mouse lymphocytes.

Authors:  Markus H Gräler; Mei-Chuan Huang; Susan Watson; Edward J Goetzl
Journal:  J Immunol       Date:  2005-02-15       Impact factor: 5.422

6.  Differential desensitization, receptor phosphorylation, beta-arrestin recruitment, and ERK1/2 activation by the two endogenous ligands for the CC chemokine receptor 7.

Authors:  Trudy A Kohout; Shelby L Nicholas; Stephen J Perry; Greg Reinhart; Sachiko Junger; R Scott Struthers
Journal:  J Biol Chem       Date:  2004-03-30       Impact factor: 5.157

Review 7.  Lysophospholipid receptors: signaling and biology.

Authors:  Isao Ishii; Nobuyuki Fukushima; Xiaoqin Ye; Jerold Chun
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

8.  TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.

Authors:  Marc Veldhoen; Richard J Hocking; Christopher J Atkins; Richard M Locksley; Brigitta Stockinger
Journal:  Immunity       Date:  2006-02       Impact factor: 31.745

9.  IL-23 drives a pathogenic T cell population that induces autoimmune inflammation.

Authors:  Claire L Langrish; Yi Chen; Wendy M Blumenschein; Jeanine Mattson; Beth Basham; Jonathan D Sedgwick; Terrill McClanahan; Robert A Kastelein; Daniel J Cua
Journal:  J Exp Med       Date:  2005-01-17       Impact factor: 14.307

10.  TGF-{beta}-dependent CD103 expression by CD8(+) T cells promotes selective destruction of the host intestinal epithelium during graft-versus-host disease.

Authors:  Riham El-Asady; Rongwen Yuan; Kechang Liu; Donghua Wang; Ronald E Gress; Philip J Lucas; Cinthia B Drachenberg; Gregg A Hadley
Journal:  J Exp Med       Date:  2005-05-16       Impact factor: 14.307

View more
  62 in total

1.  High-Resolution Expression Profiling of Peripheral Blood CD8+ Cells in Patients with Multiple Sclerosis Displays Fingolimod-Induced Immune Cell Redistribution.

Authors:  Luisa Roch; Michael Hecker; Jörg Friess; Ines Charlotte Angerer; Dirk Koczan; Brit Fitzner; Ina Schröder; Kristin Flechtner; Hans-Jürgen Thiesen; Stefanie Meister; Alexander Winkelmann; Uwe Klaus Zettl
Journal:  Mol Neurobiol       Date:  2016-09-08       Impact factor: 5.590

2.  Chronic Infection by Mucoid Pseudomonas aeruginosa Associated with Dysregulation in T-Cell Immunity to Outer Membrane Porin F.

Authors:  Kathryn J Quigley; Catherine J Reynolds; Amelie Goudet; Eleanor J Raynsford; Ruhena Sergeant; Andrew Quigley; Stefan Worgall; Diana Bilton; Robert Wilson; Michael R Loebinger; Bernard Maillere; Daniel M Altmann; Rosemary J Boyton
Journal:  Am J Respir Crit Care Med       Date:  2015-06-01       Impact factor: 21.405

Review 3.  Novel therapies for memory cells in autoimmune diseases.

Authors:  P Bhargava; P A Calabresi
Journal:  Clin Exp Immunol       Date:  2015-04-23       Impact factor: 4.330

4.  The nerve of the spleen! Causing hypertension by placental growth factor.

Authors:  Justin P Van Beusecum; David G Harrison
Journal:  Cardiovasc Res       Date:  2018-03-01       Impact factor: 10.787

5.  Receptor-interacting Ser/Thr kinase 1 (RIPK1) and myosin IIA-dependent ceramidosomes form membrane pores that mediate blebbing and necroptosis.

Authors:  Rose Nganga; Natalia Oleinik; Jisun Kim; Shanmugam Panneer Selvam; Ryan De Palma; Kristen A Johnson; Rasesh Y Parikh; Vamsi Gangaraju; Yuri Peterson; Mohammed Dany; Robert V Stahelin; Christina Voelkel-Johnson; Zdzislaw M Szulc; Erhard Bieberich; Besim Ogretmen
Journal:  J Biol Chem       Date:  2018-11-12       Impact factor: 5.157

Review 6.  Sphingosine phosphate lyase insufficiency syndrome (SPLIS): A novel inborn error of sphingolipid metabolism.

Authors:  Youn-Jeong Choi; Julie D Saba
Journal:  Adv Biol Regul       Date:  2018-09-25

7.  Effects of sphingosine-1-phosphate receptor 1 phosphorylation in response to FTY720 during neuroinflammation.

Authors:  Hsing-Chuan Tsai; Yingxiang Huang; Christopher S Garris; Monica A Moreno; Christina W Griffin; May H Han
Journal:  JCI Insight       Date:  2016-06-16

Review 8.  Regulation of human glia by multiple sclerosis disease modifying therapies.

Authors:  Luke M Healy; Mackenzie A Michell-Robinson; Jack P Antel
Journal:  Semin Immunopathol       Date:  2015-08-11       Impact factor: 9.623

9.  Systemic distribution, subcellular localization and differential expression of sphingosine-1-phosphate receptors in benign and malignant human tissues.

Authors:  Chunyi Wang; Jinghe Mao; Samantha Redfield; Yinyuan Mo; Janice M Lage; Xinchun Zhou
Journal:  Exp Mol Pathol       Date:  2014-07-30       Impact factor: 3.362

10.  Regulatory T Cell Immunotherapy in Immune-Mediated Diseases.

Authors:  Antonio Pierini; Dominik Schneidawind; Hidekazu Nishikii; Robert S Negrin
Journal:  Curr Stem Cell Rep       Date:  2015-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.